Top Banner
Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI
28

CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Feb 17, 2019

Download

Documents

voquynh
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Erre Kappa Professional DieteticsBruno Farmaceutici AmgenEli LillySigma-Tau

CONFLITTO DI INTERESSI

Page 2: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Diabete e resistenza ossea: quale legame?

P. D’Amelio MD, PhDGeriatria e Malattie Metaboliche

dell’Osso – Dipartimento di Scienze Mediche – Università di Torino

61° CONGRESSO NAZIONALE SIGG“Stiamo lavorando per farti invecchiare

meglio”: simposio SIGG-SIOMMMS

Napoli, 2 Dicembre 2013

Page 3: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cellsObesity

Page 4: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Prevalence of T2DM

Page 5: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Fragility fracture incidence

8.9 milion/yr fractures in the world (1)

1,000 fractures/hr in the world (1)

1/3 of fragility fractures occur in Europe (1)

465,000 /yr nwe fractures in Italy (2)

1. Hernlund E. et al.; Arch Osteoporos 2013; 8: 136; 2. Svedbom A. et al.; Arch Osteoporos 2013; 8: 317

The number of fractures/yrs is increasing (2)

Page 6: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Mohsen Janghorbani et al. Am. J. Epidemiol. 2007

Diabetic patients (T2DM) have increasedrisk of fractures (1)

Page 7: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Strotmeyer ES et al. Arch Intern Med. 2005

Diabetic patients (T2DM) have increasedrisk of fractures (2)

Page 8: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Mohsen Janghorbani et al. Am. J. Epidemiol. 2007

Diabetic patients (T1DM) have increasedrisk of fractures (3)

Page 9: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Factors leading to fractures in diabetics

DM 1 DM2

Increased bone resorption and decreased/unaltered bone formation

Low bone turnover

Hyperglycemia Hyperglycemia

Increased propensity to falldue to acute hypoglycemia and comorbid complications (eg retinopathy, neuropathy, cerebrovascular disease)

Increased propensity to falldue to acute hypoglycemia and comorbid complications (eg retinopathy, neuropathy, cerebrovascular disease)

Low bone mass Accelerated bone loss with aging

Page 10: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cellsObesity

Page 11: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

ROLE OF AGEs

Page 12: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Bone Formation is Affected by Matrix AGEs (1)

Yang X et al. Calcif Tissue Int. 2016

Page 13: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Bone Formation is Affected by Matrix AGEs (2)

Mechanical parameter

Control groupAGEs-treated

groupp

Elastic modulus (GPa)

12.7 ± 3.23 12.6 ± 0.823 0.93

Hardness 0.568 ± 0.171 0.587 ± 0.268 0.89

Mechanical properties of newly formed bone

Yang X et al. Calcif Tissue Int. 2016

Page 14: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cells

Page 15: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Burghardt AJ, et al. J Clin Endocrinol Metab. 2010

Diabetes influence bone structure …

Page 16: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Patsch J.M, et al. J Bone Miner Res. 2013

Diabetes influence bone structure independently by bone density

Page 17: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Farr J N. and Khosla S. Bone 2016

Bone material properties

Page 18: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cellsObesity

Page 19: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Diabetes Mellitus type II and Bone

Reduced recruitment of OB (in animals)

Reduced appositional rate (in animals)

Decreased bone formation (in humans)

Decreased bone resorption

Decreased bone turnover OC OPG

Page 20: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Sanguineti R, et al. Ann NY Acad Sci. 2008

AGEs affect osteoblasts formation and activity

Page 21: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Gennari L. et al; The Journal of Clinical Endocrinology & Metabolism 2012

Diabetes Mellitus type II and Bone Turnover

Page 22: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

T2DM affects bone precursors cell

D’Amelio et al. manuscript in preparation

Page 23: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cellsObesity

Page 24: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Cohen A et al. The Journal of Clinical Endocrinology & Metabolism 2013

Obesity is associated with lowerbone volume and formation

Page 25: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

Cohen A et al. The Journal of Clinical Endocrinology & Metabolism 2013

Obesity is associated with poor bone quality

Page 26: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

AGENDA

• Epidemiology and fracture risk

• How T2DM affects bone

• Conclusions

AGEs Bone quality Bone turnover and cellsObesity

Page 27: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI
Page 28: CONFLITTO DI INTERESSI - sigg.itAmelio.pdf · Erre Kappa Professional Dietetics Bruno Farmaceutici Amgen Eli Lilly Sigma-Tau CONFLITTO DI INTERESSI

GRAZIE